TricodeGF (Respa Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Tricode drug offered from Respa Pharmaceuticals, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Respa Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | Codeine Phosphate, Guaifenesin, Pseudoephedrine Hydrochloride |
SUBSTANCE NAME: | CODEINE PHOSPHATE; GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | LIQUID |
MARKETING CATEGORY NAME: | OTC MONOGRAPH FINAL |
START MARKETING DATE: | 2011-06-20 |
END MARKETING DATE: | 0000-00-00 |
Tricode GF HUMAN OTC DRUG Details:
Item Description | Tricode GF from Respa Pharmaceuticals, Inc. |
LABELER NAME: | Respa Pharmaceuticals, Inc. |
DEA SCHEDULE: | CV
|
ACTIVE STRENGTH: | 8; 200; 30(mg/5mL; mg/5mL; mg/5mL) |
START MARKETING DATE: | 2011-06-20 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 60575-414_ba3af78f-2f38-48c7-94bf-36416da895a5 |
PRODUCT NDC: | 60575-414 |
APPLICATION NUMBER: | part341 |
Other CODEINE PHOSPHATE; GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: